Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

被引：0
|
作者：
Min Chong Kim
Jung Eun Choi
Soo Jung Lee
Young Kyung Bae
机构：
[1] Yeungnam University College of Medicine,Department of Pathology
[2] Yeungnam University College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Breast Cancer; Overall Survival; TP53 Mutation; Hormone Receptor Status; Sporadic Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3524 / 3530
页数：6
相关论文
共 50 条
  • [1] Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Kim, Min Chong
    Choi, Jung Eun
    Lee, Soo Jung
    Bae, Young Kyung
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3524 - 3530
  • [2] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [3] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [4] A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Ma, Fei
    Ding, Xiaoyan
    Fan, Ying
    Ying, Jianming
    Zheng, Shan
    Lu, Ning
    Xu, Binghe
    PLOS ONE, 2014, 9 (11):
  • [5] Effectiveness of microRNA expressions and PARP inhibitors for triple-negative breast cancer with BRCA1 mutations
    Sasaki, Akiko
    Tsunoda, Yuko
    Tsuji, Mayumi
    Udaka, Yuko
    Oyamada, Hideto
    Oguchi, Katsuji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 170P - 170P
  • [6] Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
    Ohi, Yasuyo
    Umekita, Yoshihisa
    Yoshioka, Takako
    Souda, Masakazu
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    Sagara, Yoshiatsu
    Tanimoto, Akihide
    HISTOPATHOLOGY, 2011, 59 (04) : 776 - 780
  • [7] Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer
    Bae, Soo Youn
    Nam, Seok Jin
    Jung, Yongsik
    Lee, Sae Byul
    Park, Byung-Woo
    Lim, Woosung
    Jung, Sung Hoo
    Yang, Hsien Wen
    Jung, Seung Pil
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (02) : 437 - 444
  • [8] Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
    Xu, Y.
    Diao, L.
    Chen, Y.
    Liu, Y.
    Wang, C.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Deng, D.
    Narod, S. A.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1498 - 1505
  • [9] Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer
    Soo Youn Bae
    Seok Jin Nam
    Yongsik Jung
    Sae Byul Lee
    Byung-Woo Park
    Woosung Lim
    Sung Hoo Jung
    Hsien Wen Yang
    Seung Pil Jung
    Breast Cancer Research and Treatment, 2018, 172 : 437 - 444
  • [10] P53, BRCA1 and breast cancer chemoresistance
    Scata, Kimberly A.
    El-Deiry, Wafik S.
    BREAST CANCER CHEMOSENSITIVITY, 2007, 608 : 70 - 86
12345